ArticleJournal of fluorescence2026
N, Zn-CDs: AgNPs-Induced "Off-On" Fluorescence Sensor for Cysteamine Detection in Biological Media.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Developing efficient, stable cysteamine detection methods is crucial for early toxicity warning and the protection of human health. Herein, we have developed an innovative, highly sensitive, selective, and stable “off-on” composite fluorescent probe composed of N, Zn-CDs and AgNPs. This probe incorporates surface plasmon resonance, the internal filter effect, and photoinduced electron transfer quenching mechanisms, characterized by dual recovery pathways mediated through S-Ag bonds and hydrogen bonding interactions. By employing an orthogonal experimental design to optimize the hydrothermal synthesis process, this study addresses the limitations inherent in existing probes, such as namely low fluorescence quantum yield, inadequate sensitivity, poor resistance to interference, and the release of toxic ions. The synthesized N, Zn-CDs showed a 59.6% fluorescence quantum yield (47.7% higher than undoped CDs). The N, Zn-CDs/AgNPs probe exhibited linear response to cysteamine (0.01–0.1 µM, R²=0.9972) with a detection limit as low as 3 nM. The synthesized N, Zn-CDs demonstrated good stability under continuous ultraviolet irradiation, in high-salinity environments, and at neutral pH conditions. The probe’s selectivity for cysteamine was approximately 3.5 times greater than for other amino acids, indicating good resistance to interference. Recovery experiments in spiked bovine serum samples yielded rates between 95.0 ± 0.92% and 102.8 ± 1.56% (RSD < 2%), further supporting the probe’s reliability. Cytotoxicity assessments confirmed the probe’s low toxicity and favorable biocompatibility. This probe provides a practical method for the efficient and stable quantitative analysis of cysteamine. Furthermore, the synergistic doping of zinc and nitrogen offers novel perspectives for the development of low-toxicity, high-performance carbon dot-based probes.
Indexed as
Identifiers
41761032What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.